Skip to main content
AddLife logo

AddLife — Investor Relations & Filings

Ticker · ALIF ISIN · SE0014401378 LEI · 5493005T3M7CD7XWE013 ST Wholesale and retail trade
Open in API
Filings indexed 294 across all filing types
Latest filing 2016-04-05 Share Issue/Capital Cha…
Country SE Sweden
Listing ST ALIF

About AddLife

https://www.add.life/

AddLife is a life science group that operates through a decentralized model, acquiring and developing market-leading companies in niche segments. The group consists of numerous independent subsidiaries that provide specialized products, services, and advisory support primarily to the healthcare and research sectors. Its offerings encompass a broad range of instruments, equipment, consumables, and advanced solutions for diagnostics, medical technology, and biomedical research and laboratory analysis. AddLife's business strategy focuses on combining the strength and resources of a large enterprise with the entrepreneurial drive and agility of its subsidiaries, fostering growth and innovation while preserving the unique culture of each acquired company.

Recent filings

Filing Released Lang Actions
AddLife publishes prospectus supplement
Share Issue/Capital Change Classification · 95% confidence The document is a press release titled "AddLife publishes prospectus supplement" dated April 5, 2016. It discusses the resolution of a share issue with preferential rights, the approval of a prospectus supplement by the Swedish Financial Supervisory Authority, and where this supplement can be found (company website and financial advisor's website). This document is announcing the availability of a key financing/securities document (the prospectus supplement) related to a share issue. Since the core action is the publication/availability of a document related to capital raising, it strongly aligns with the 'Capital/Financing Update' (CAP) category, which covers fundraising and capital structure changes. Although it announces a document, the content is primarily about the financing terms themselves, making CAP more specific than RPA or RNS. The document length (3265 chars) is short, but the focus is on the financing terms rather than just announcing the report's release time.
2016-04-05 English
AddLife offentliggör tilläggsprospekt
Capital/Financing Update Classification · 95% confidence The document is a press release titled "AddLife offentliggör tilläggsprospekt" (AddLife publishes supplementary prospectus). It announces that a supplementary prospectus related to a rights issue ("företrädesemissionen") has been approved and registered by the Swedish Financial Supervisory Authority (Finansinspektionen). It also mentions previous announcements regarding financing activities (the rights issue) and acquisitions. Since the document is an announcement about the publication/registration of a prospectus related to a capital raising/financing event (rights issue), it strongly aligns with the Capital/Financing Update category (CAP). Although it announces a document, the core subject matter is the financing terms and the approval of the related prospectus, making CAP more specific than a general RPA or RNS. The document length (3127 chars) is short, but the content is a direct update on a financing structure, not just a notice that a report is available.
2016-04-05 Swedish
AddLife signs agreement to represent Leica Biosystems operations in Sweden and Denmark
Regulatory Filings Classification · 99% confidence The document announces a significant business agreement where AddLife will represent Leica Biosystems in Sweden and Denmark, detailing the scope, expected financial impact (marginally positive EPS), and the transfer date. This is a material corporate event announcement that does not fit the definitions for standard financial reports (10-K, IR, ER), management changes (MANG), or capital structure changes (CAP, SHA). It is a specific business development announcement. Since there is no specific category for 'Business Acquisition/Representation Agreement,' and it is not a standard regulatory filing like a Director's Dealing or Major Shareholding change, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a disclosure made under Swedish securities regulations ('This information is disclosed in accordance with the Swedish Securities Markets Act...').
2016-04-04 English
AddLife tecknar avtal om att representera Leica Biosystems i Sverige och Danmark
M&A Activity Classification · 99% confidence The document announces a significant business event: AddLife signing an agreement to represent Leica Biosystems in Sweden and Denmark, which involves taking over sales and service operations. This is a material corporate action related to business structure and operations, but it does not fit neatly into standard SEC filings like 10-K, ER, or IR. It is a specific announcement regarding a business transaction/partnership. Given the options, this type of announcement, which is material but not a formal M&A filing (TAR), financing event (CAP), or director dealing (DIRS), is best categorized as a general regulatory announcement or a miscellaneous corporate event filing. Since it is a specific, material announcement released to the public market (as indicated by the final paragraph referencing securities market laws and NASDAQ Stockholm), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for specific corporate news that doesn't match other codes.
2016-04-04 Swedish
Conversion of shares in AddLife AB (publ)
Share Issue/Capital Change Classification · 98% confidence The document explicitly details a change in the company's share structure: the conversion of Class A shares to Class B shares, which affects the total number of votes and the breakdown of share classes. This action directly relates to the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes to the capital structure, including share class conversions that alter voting rights and share counts. It is not an earnings release, a full annual report, or a simple dividend announcement. Given the specific nature of the change, SHA is the most appropriate classification over the general 'RNS' fallback.
2016-03-31 English
Omvandling av aktier i AddLife AB (publ)
Share Issue/Capital Change Classification · 98% confidence The document explicitly discusses the conversion of Series A shares to Series B shares, resulting in a change in the total number of votes and the total number of registered shares. This action directly impacts the company's capital structure (share count and voting rights). This aligns best with the 'Share Issue/Capital Change' definition (SHA), which covers changes to the capital structure, including share class conversions that affect voting rights. It is not a general financing update (CAP), nor is it a director's dealing (DIRS) or a dividend notice (DIV). Given the specific nature of the capital structure change, SHA is the most appropriate classification.
2016-03-31 Swedish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.